Showing results (111-120 of 169) with videos related to

Sort By:
Pageof 17
Transplantation|June 1, 1985
The impact of renal transplantation on the course of hepatitis B liver diseaseP S Parfrey, R D Forbes, T A Hutchinson, et al.
Annals of the Rheumatic Diseases|July 16, 2008
Geographical variation of disease manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research (EUSTAR) group databaseU A Walker, A Tyndall, L Czirják, et al.
Revista Medico-Chirurgicala a Societatii De Medici Si Naturalisti Din Iasi|July 2, 2002
[Prognosis and treatment of membranous glomerulonephritis-a 5-year prospective study]A Covic, I D Căruntu, D Marian, et al.
Nucleic Acids Research|January 11, 2000
Comparison of the Escherichia coli K-12 genome with sampled genomes of a Klebsiella pneumoniae and three salmonella enterica serovars, Typhimurium, Typhi and ParatyphiM McClelland, L Florea, K Sanderson, et al.
Journal De Medecine Vasculaire|December 6, 2017
[New international guidelines for curative treatment and prophylaxis for venous thromboembolism (VTE) in cancer patients and the dedicated smartphone application]I Benzidia, J Connault, A Solanilla, et al.
Current Research in Translational Medicine|October 22, 2016
Major bleeding complications in patients treated with direct oral anticoagulants: One-year observational study in a Paris HospitalL Deville, M Konan, A Hij, et al.
Annals of the Rheumatic Diseases|May 29, 2007
Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosisJ Larghero, D Farge, A Braccini, et al.
La Revue De Medecine Interne|January 23, 2004
[Quality of life assessment with the MOS-SF36 in patients with systemic sclerosis]C Georges, O Chassany, L Mouthon, et al.
La Revue De Medecine Interne|May 2, 2009
[Follow-up with the assistance of TB-info software of 208 tuberculosis patients who were treated in 2004]A Bourgarit, H-P Mallet, H Keshtmand, et al.
Annals of the Rheumatic Diseases|January 20, 2007
Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group databaseU A Walker, A Tyndall, L Czirják, et al.
Pageof 17